Bridgebio Pharma, Inc. · NASDAQ:BBIO

Viking Global Investors LP reported a 8.20% stake in Bridgebio Pharma, Inc. (Schedule 13D/A)

Event Nov 14, 2025 · Filed Nov 14, 2025

Viking Global Investors LP reported a 8.20% stake in Bridgebio Pharma, Inc., 15,893,934 shares, with active intent on Nov 14, 2025. Filed Nov 14, 2025 (Schedule 13D/A).

Stake
8.20%
Shares
15,893,934
Intent
Active
What changed
Stake changed
Filed together
14 holders

The filing in full

HolderStakeShares
VIKING GLOBAL INVESTORS LP8.20%15,893,934
VIKING GLOBAL PERFORMANCE LLC0%0
Viking Global Equities II LP0%0
Viking Global Equities Master Ltd.0%0
Viking Long Fund GP LLC0%0
Viking Long Fund Master Ltd.0%0
Viking Global Opportunities Parent GP LLC8.20%15,893,934
Viking Global Opportunities GP LLC8.20%15,893,934
Viking Global Opportunities Portfolio GP LLC8.20%15,893,934
Viking Global Opportunities Illiquid Investments Sub-Master LP8.20%15,893,934
Viking Global Opportunities Liquid Portfolio Sub-Master LP0%0
HALVORSEN OLE ANDREAS8.20%15,893,934
Ott David C.8.20%15,893,934
Shabet Rose Sharon8.20%15,893,934

Source

View original at SEC

Related